These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 28492833)

  • 41. Osteoporosis, an Update.
    Hamdy RC
    J Clin Densitom; 2017; 20(2):131. PubMed ID: 28449814
    [No Abstract]   [Full Text] [Related]  

  • 42. Antiresorptive treatment, when initiated after a first hip fracture, may not protect of a second contralateral episode in elderly population: A study with 685 patients.
    Besalduch M; Carrera I; Gómez-Masdeu M; De Caso J
    Injury; 2016 Apr; 47(4):877-80. PubMed ID: 26892501
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of treatments for osteoporosis on mortality.
    Grey A; Bolland MJ
    Osteoporos Int; 2013 Jan; 24(1):1-6. PubMed ID: 23076683
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Osteoporosis management in 2017: still thin and fragmented.
    Sheu A; Lopes LBA; Eisman J; Center JR
    Intern Med J; 2017 Nov; 47(11):1329-1330. PubMed ID: 29105266
    [No Abstract]   [Full Text] [Related]  

  • 45. Glucocorticoid-induced Osteoporosis.
    Whittier X; Saag KG
    Rheum Dis Clin North Am; 2016 Feb; 42(1):177-89, x. PubMed ID: 26611558
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone mineral density loss, osteoporosis, and fractures in HIV.
    Labarga P
    AIDS Rev; 2013; 15(3):189-90. PubMed ID: 24002203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bisphosphonate-related atypical femoral fracture: Managing a rare but serious complication.
    Silverman S; Kupperman E; Bukata S
    Cleve Clin J Med; 2018 Nov; 85(11):885-893. PubMed ID: 30395525
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Secondary prevention of osteoporotic fractures. How well are we doing?].
    Kyriakos G; Vidal-Casariego A; Quiles-Sánchez LV; Cano-Rodríguez I
    Semergen; 2017 Apr; 43(3):254-255. PubMed ID: 27102950
    [No Abstract]   [Full Text] [Related]  

  • 49. [Risk adapted treatment of osteoporosis].
    Schute L
    Dtsch Med Wochenschr; 2011 Jul; 136(27):1440; author reply 1440. PubMed ID: 21713725
    [No Abstract]   [Full Text] [Related]  

  • 50. Fracture prevention: a population-based intervention delivered in primary care.
    Hoggard K; Hart S; Birchall J; Kirk S; Goff I; Grove M; Newton J
    QJM; 2020 May; 113(5):313-319. PubMed ID: 31670784
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Osteoporosis-Assessing Fracture Risk.
    Hamdy RC
    J Clin Densitom; 2017; 20(3):271. PubMed ID: 28732578
    [No Abstract]   [Full Text] [Related]  

  • 52. Drugs for the treatment of metabolic bone diseases.
    Drake MT; Cremers S; Russell RG; Bilezikian JP
    Br J Clin Pharmacol; 2019 Jun; 85(6):1049-1051. PubMed ID: 30950086
    [No Abstract]   [Full Text] [Related]  

  • 53. Subjects with osteoporosis to remain at high risk for fracture despite benefit of prior bisphosphonate treatment-a Danish case-control study.
    Hansen L; Petersen KD; Eriksen SA; Gerstoft F; Vestergaard P
    Osteoporos Int; 2017 Jan; 28(1):321-328. PubMed ID: 27475930
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Screening for osteoporosis: recommendation statement.
    U.S. Preventive Services Task Force
    Am Fam Physician; 2011 May; 83(10):1197-200. PubMed ID: 21568254
    [No Abstract]   [Full Text] [Related]  

  • 55. [Metabolic bone diseases: benefits and risks of the treatment].
    Rizzoli R
    Rev Med Suisse; 2009 Jun; 5(207):1299-300. PubMed ID: 19626928
    [No Abstract]   [Full Text] [Related]  

  • 56. Bisphosphonates.
    Reid IR
    Skeletal Radiol; 2007 Aug; 36(8):711-4. PubMed ID: 17340165
    [No Abstract]   [Full Text] [Related]  

  • 57. Randomised trial assessing the impact of framing of fracture risk and osteoporosis treatment benefits in patients undergoing bone densitometry.
    Kalluru R; Petrie KJ; Grey A; Nisa Z; Horne AM; Gamble GD; Bolland MJ
    BMJ Open; 2017 Feb; 7(2):e013703. PubMed ID: 28188155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Study on Zoledronic Acid Reducing Acute Bone Loss and Fracture Rates in Elderly Postoperative Patients with Intertrochanteric Fractures.
    Liu Z; Li CW; Mao YF; Liu K; Liang BC; Wu LG; Shi XL
    Orthop Surg; 2019 Jun; 11(3):380-385. PubMed ID: 31058448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 60. How to use bisphosphonates safely and optimally.
    Jagpal A; Saag KG
    Rheumatology (Oxford); 2018 Nov; 57(11):1875-1876. PubMed ID: 29165674
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.